{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:57:11Z","timestamp":1791233831551,"version":"4.1.0"},"reference-count":26,"publisher":"American Society of Parasitologists","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Parasitology"],"published-print":{"date-parts":[[2026,8,28]]},"abstract":"<jats:p>Antimicrobial resistance has become a major global health challenge, creating an urgent need for novel anti-infective molecules. Antimicrobial peptides (AMPs) constitute a promising alternative to conventional antibiotics because of their broad-spectrum antimicrobial activity and immunomodulatory properties. Despite the remarkable diversity of protozoa, very few protozoan AMPs have been experimentally identified. Here, we employed the deep learning algorithm AMPlify to systematically screen the proteomes of Blastocystis hominis, Trypanosoma cruzi, Leishmania major, Toxoplasma gondii, and Entamoeba histolytica for high-confidence AMP candidates. Candidate proteins with prediction probabilities greater than 0.90 were further annotated by sequence similarity searches and prioritized for experimental validation. We identified 48 candidate AMPs in B. hominis, 27 in T. cruzi, 23 in T. gondii, and 24 in E. histolytica, whereas no high-confidence candidates were detected in L. major. Predicted candidates represented diverse functional classes, including ribosomal proteins, enzymes, membrane-associated proteins, and proteins involved in nucleic acid metabolism. Three peptides were synthesized and evaluated against Escherichia coli K12. Among them, a peptide derived from the 60S ribosomal protein L3 of B. hominis inhibited bacterial growth with a minimum inhibitory concentration of 125 \u00b5M, whereas peptides derived from ribosomal protein L8 and T. cruzi trans-sialidase showed no detectable activity. These findings demonstrate the utility of deep learning for prioritizing novel AMP candidates while highlighting the importance of experimental validation. The identified candidates provide a valuable resource for future functional studies and the development of peptide-based antimicrobial therapeutics.<\/jats:p>","DOI":"10.1645\/25-99","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T05:03:46Z","timestamp":1788930226000},"page":"514-520","source":"Crossref","is-referenced-by-count":0,"title":["Deep Learning Prediction of Antimicrobial Peptides in Protozoa"],"prefix":"10.1645","volume":"112","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2673-2202","authenticated-orcid":false,"given":"Fabiano","family":"Pinheiro da Silva","sequence":"first","affiliation":[{"name":"Laborat\u00f3rio de Emerg\u00eancias Cl\u00ednicas, Faculdade de Medicina da Universidade de S\u00e3o Paulo, Av Dr Arnaldo, 455 - CEP 01246-903, S\u00e3o Paulo - SP, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suely Kubo","family":"Ariga","sequence":"additional","affiliation":[{"name":"Laborat\u00f3rio de Emerg\u00eancias Cl\u00ednicas, Faculdade de Medicina da Universidade de S\u00e3o Paulo, Av Dr Arnaldo, 455 - CEP 01246-903, S\u00e3o Paulo - SP, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thais","family":"Martins de Lima","sequence":"additional","affiliation":[{"name":"Laborat\u00f3rio de Emerg\u00eancias Cl\u00ednicas, Faculdade de Medicina da Universidade de S\u00e3o Paulo, Av Dr Arnaldo, 455 - CEP 01246-903, S\u00e3o Paulo - SP, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o Marcelo","family":"Pereira Alves","sequence":"additional","affiliation":[{"name":"Departamento de Parasitologia, Instituto de Ci\u00eancias Biom\u00e9dicas, Universidade de S\u00e3o Paulo, Av Lineu Prestes, 1374 - CEP 05508-000, S\u00e3o Paulo - SP, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1220","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"M. N. Anahtar, J. H. Yang, S. Kanjilal,  \"Journal of Clinical Microbiology.\"  59, \"Applications of machine learning to the problem of antimicrobial resistance: An emerging model for translational research.\" e0126020 (2021)","DOI":"10.1128\/JCM.01260-20"},{"key":"2","doi-asserted-by":"publisher","unstructured":"K. M. Da Costa, L. Marques Da Fonseca, J. S. Dos Reis, et al.  \"Frontiers in Cellular and Infection Microbiology.\"  11, \"Trypanosoma cruzi trans-sialidase as a potential vaccine target against Chagas disease.\" 768450 (2021)","DOI":"10.3389\/fcimb.2021.768450"},{"key":"3","doi-asserted-by":"publisher","unstructured":"J. M. P. De La Lastra, S. J. T. Wardell, T. Pal, et al.  \"Journal of Medical Systems.\"  48, \"From data to decisions: Leveraging artificial intelligence and machine learning in combating antimicrobial resistance - a comprehensive review.\" 71 (2024)","DOI":"10.1007\/s10916-024-02089-5"},{"key":"4","doi-asserted-by":"crossref","unstructured":"A. C. Frasch,  \"Parasitology Today.\"  16, \"Functional diversity in the trans-sialidase and mucin families in Trypanosoma cruzi.\" 282 (2000)","DOI":"10.1016\/S0169-4758(00)01698-7"},{"key":"5","doi-asserted-by":"crossref","unstructured":"L. Freire-De-Lima, L. M. Fonseca, T. Oeltmann, et al.  \"Glycobiology.\"  25, \"The trans-sialidase, the major Trypanosoma cruzi virulence factor: Three decades of studies.\" 1142 (2015)","DOI":"10.1093\/glycob\/cwv057"},{"key":"6","doi-asserted-by":"crossref","unstructured":"R. E. Hancock, E. F. Haney, E. E. Gill,  \"Nature Reviews Immunology.\"  16, \"The immunology of host defence peptides: Beyond antimicrobial activity.\" 321 (2016)","DOI":"10.1038\/nri.2016.29"},{"key":"7","doi-asserted-by":"crossref","unstructured":"G. C. Hansson,  \"Annual Review of Biochemistry.\"  89, \"Mucins and the Microbiome.\" 769 (2020)","DOI":"10.1146\/annurev-biochem-011520-105053"},{"key":"8","doi-asserted-by":"publisher","unstructured":"J. J. Hurtado-Rios, U. Carrasco-Navarro, J. C. Almanzaperez, et al.  \"International Journal of Molecular Sciences.\"  23, \"Ribosomes: The new role of ribosomal proteins as natural antimicrobials.\" 9123 (2022)","DOI":"10.3390\/ijms23169123"},{"key":"9","doi-asserted-by":"publisher","unstructured":"C. Li, D. Sutherland, S. A. Hammond, et al.  \"BMC Genomics.\"  23, \"AMPlify: Attentive deep learning model for discovery of novel antimicrobial peptides effective against WHO priority pathogens.\" 77 (2022)","DOI":"10.1186\/s12864-022-08310-4"},{"key":"10","doi-asserted-by":"publisher","unstructured":"J. Lv, G. Liu, X. Zhou, et al.  \"Probiotics and Antimicrobial Proteins.\"  \"Artificial intelligence-driven antimicrobial peptide discovery: Prediction, generation, mining and optimization.\" (2026)","DOI":"10.1007\/s12602-026-11013-x"},{"key":"11","doi-asserted-by":"crossref","unstructured":"M. Magana, M. Pushpanathan, A. L. Santos, et al.  \"Lancet Infectious Diseases.\"  20, \"The value of antimicrobial peptides in the age of resistance.\" e216 (2020)","DOI":"10.1016\/S1473-3099(20)30327-3"},{"key":"12","doi-asserted-by":"crossref","unstructured":"M. Mahjoubin-Tehran, S. Rezaei, S. H. Aghaee-Bakhtiari, et al.  \"Current Topics in Medicinal Chemistry.\"  23, \"Harnessing the therapeutic potential of antimicrobial peptides for cancers: State of the art.\" 1542 (2023)","DOI":"10.2174\/1568026623666230328161236"},{"key":"13","doi-asserted-by":"publisher","unstructured":"M. Mahlapuu, J. Hakansson, L. Ringstad, et al.  \"Frontiers in Cellular and Infection Microbiology.\"  6, \"Antimicrobial peptides: An emerging category of therapeutic agents.\" 194 (2016)","DOI":"10.3389\/fcimb.2016.00194"},{"key":"14","doi-asserted-by":"crossref","unstructured":"M. Munoz, M. Craske, P. Severino, et al.  \"Journal of Cancer.\"  7, \"Antimicrobial peptide LL-37 participates in the transcriptional regulation of melanoma cells.\" 2341 (2016)","DOI":"10.7150\/jca.16947"},{"key":"15","doi-asserted-by":"crossref","unstructured":"A. Peschel  and H. G. Sahl  \"Nature Reviews Microbiology.\"  4, \"The co-evolution of host cationic antimicrobial peptides and microbial resistance.\" 529 (2006)","DOI":"10.1038\/nrmicro1441"},{"key":"16","doi-asserted-by":"crossref","unstructured":"F. Pinheiro Da Silva  and M. C. Machado  \"Peptides.\"  36, \"Antimicrobial peptides: Clinical relevance and therapeutic implications.\" 308 (2012)","DOI":"10.1016\/j.peptides.2012.05.014"},{"key":"17","doi-asserted-by":"crossref","unstructured":"F. Pinheiro Da Silva, M. C. Medeiros, A. B. Dos Santos, et al.  \"Tissue and Cell.\"  45, \"Neutrophils LL-37 migrate to the nucleus during overwhelming infection.\" 318 (2013)","DOI":"10.1016\/j.tice.2013.04.003"},{"key":"18","doi-asserted-by":"publisher","unstructured":"Y. H. Sheng  and S. Z. Hasnain  \"Frontiers in Cellular and Infection Microbiology.\"  12, \"Mucus and Mucins: The underappreciated host defence system.\" 856962 (2022)","DOI":"10.3389\/fcimb.2022.856962"},{"key":"19","doi-asserted-by":"publisher","unstructured":"P. Szymczak  and E. Szczurek  \"Current Opinion in Structural Biology.\"  83, \"Artificial intelligence-driven antimicrobial peptide discovery.\" 102733 (2023)","DOI":"10.1016\/j.sbi.2023.102733"},{"key":"20","doi-asserted-by":"publisher","unstructured":"L. Tajer, J. C. Paillart, H. Dib, et al.  \"Microorganisms.\"  12, \"Molecular mechanisms of bacterial resistance to antimicrobial peptides in the modern era: An updated review.\" 1259 (2024)","DOI":"10.3390\/microorganisms12071259"},{"key":"21","doi-asserted-by":"publisher","unstructured":"A. M. Van Der Does, P. S. Hiemstra, N. Mookherjee,  \"Advances in Experimental Medicine and Biology.\"  1117, \"Antimicrobial host defence peptides: Immunomodulatory functions and translational prospects.\" 149 (2019)","DOI":"10.1007\/978-981-13-3588-4_10"},{"key":"22","doi-asserted-by":"publisher","unstructured":"G. Wang, X. Li, Z. Wang,  \"Nucleic Acids Research.\"  44, \"APD3: The antimicrobial peptide database as a tool for research and education.\" D1087 (2016)","DOI":"10.1093\/nar\/gkv1278"},{"key":"23","doi-asserted-by":"publisher","unstructured":"H. Wang, C. Zhang, M. Li, et al.  \"International Journal of Molecular Sciences.\"  23, \"Antimicrobial peptides mediate apoptosis by changing mitochondrial membrane permeability.\" 12732 (2022)","DOI":"10.3390\/ijms232112732"},{"key":"24","doi-asserted-by":"publisher","unstructured":"J. R. Warner  and K. B. Mcintosh  \"Molecular Cell.\"  34, \"How common are extra-ribosomal functions of ribosomal proteins?\" 3 (2009)","DOI":"10.1016\/j.molcel.2009.03.006"},{"key":"25","doi-asserted-by":"publisher","unstructured":"F. Wong, C. De La Fuente-Nunex, J. J. Collins,  \"Science.\"  381, \"Leveraging artificial intelligence in the fight against infectious diseases.\" 164 (2023)","DOI":"10.1126\/science.adh1114"},{"key":"26","doi-asserted-by":"publisher","unstructured":"Y. Zhou, Y. Yang, D. Zhao, et al.  \"Fish & Shellfish Immunology.\"  152, \"Ribosomal protein L17 functions as an antimicrobial protein in amphioxus.\" 109781 (2024)","DOI":"10.1016\/j.fsi.2024.109791"}],"container-title":["Journal of Parasitology"],"original-title":[],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:30:51Z","timestamp":1791232251000},"score":1,"resource":{"primary":{"URL":"https:\/\/bioone.org\/journals\/journal-of-parasitology\/volume-112\/issue-4\/25-99\/Deep-Learning-Prediction-of-Antimicrobial-Peptides-in-Protozoa\/10.1645\/25-99.full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,28]]},"references-count":26,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,7,1]]}},"URL":"https:\/\/doi.org\/10.1645\/25-99","relation":{},"ISSN":["0022-3395","1937-2345"],"issn-type":[{"value":"0022-3395","type":"print"},{"value":"1937-2345","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,28]]}}}